
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PEX1
Introduction
Peroxisome biogenesis factor 1, also known as PEX1, is a protein which in humans is encoded by the PEX1 gene.[1]
This gene encodes a member of the AAA protein family, a large group of ATPases associated with diverse cellular activities. This protein is cytoplasmic but is often anchored to a peroxisomal membrane where it forms a heteromeric complex and plays a role in the import of proteins into peroxisomes and peroxisome biogenesis. Mutations in this gene have been associated with complementation group 1 peroxisomal disorders such as neonatal adrenoleukodystrophy, infantile Refsum disease, and Zellweger syndrome.[1]
References
References
- ↑ 1.0 1.1 “Entrez Gene: PEX1 peroxisome biogenesis factor 1”.
- ↑ Tamura, S; Shimozawa N; Suzuki Y; Tsukamoto T; Osumi T; Fujiki Y (Apr 1998). “A cytoplasmic AAA family peroxin, Pex1p, interacts with Pex6p”. Biochem. Biophys. Res. Commun. UNITED STATES. 245 (3): 883–6. doi:10.1006/bbrc.1998.8522. ISSN 0006-291X. PMID 9588209.
- ↑ Geisbrecht, B V; Collins C S; Reuber B E; Gould S J (Jul 1998). “Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease”. Proc. Natl. Acad. Sci. U.S.A. UNITED STATES. 95 (15): 8630–5. Bibcode:1998PNAS…95.8630G. doi:10.1073/pnas.95.15.8630. ISSN 0027-8424. PMC 21127. PMID 9671729.
- ↑ Matsumoto, Naomi; Tamura Shigehiko; Fujiki Yukio (May 2003). “The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes”. Nat. Cell Biol. England. 5 (5): 454–60. doi:10.1038/ncb982. ISSN 1465-7392. PMID 12717447.
Further reading
Further reading
- Wanders RJ (2004). “Metabolic and molecular basis of peroxisomal disorders: a review”. Am. J. Med. Genet. A. 126 (4): 355–75. doi:10.1002/ajmg.a.20661. PMID 15098234.
- Crane DI, Maxwell MA, Paton BC (2006). “PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders”. Hum. Mutat. 26 (3): 167–75. doi:10.1002/humu.20211. PMID 16086329.
- Naritomi K, Izumikawa Y, Ohshiro S, et al. (1990). “Gene assignment of Zellweger syndrome to 7q11.23: report of the second case associated with a pericentric inversion of chromosome 7”. Hum. Genet. 84 (1): 79–80. doi:10.1007/BF00210677. PMID 2606480.
- Reuber BE, Germain-Lee E, Collins CS, et al. (1997). “Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders”. Nat. Genet. 17 (4): 445–8. doi:10.1038/ng1297-445. PMID 9398847.
- Portsteffen H, Beyer A, Becker E, et al. (1997). “Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders”. Nat. Genet. 17 (4): 449–52. doi:10.1038/ng1297-449. PMID 9398848.
- Faber KN, Heyman JA, Subramani S (1998). “Two AAA family peroxins, PpPex1p and PpPex6p, interact with each other in an ATP-dependent manner and are associated with different subcellular membranous structures distinct from peroxisomes”. Mol. Cell. Biol. 18 (2): 936–43. PMC 108805. PMID 9447990.
- Tamura S, Okumoto K, Toyama R, et al. (1998). “Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I.” Proc. Natl. Acad. Sci. U.S.A. 95 (8): 4350–5. Bibcode:1998PNAS…95.4350T. doi:10.1073/pnas.95.8.4350. PMC 22492. PMID 9539740.
- Tamura S, Shimozawa N, Suzuki Y, et al. (1998). “A cytoplasmic AAA family peroxin, Pex1p, interacts with Pex6p”. Biochem. Biophys. Res. Commun. 245 (3): 883–6. doi:10.1006/bbrc.1998.8522. PMID 9588209.
- Geisbrecht BV, Collins CS, Reuber BE, Gould SJ (1998). “Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease”. Proc. Natl. Acad. Sci. U.S.A. 95 (15): 8630–5. Bibcode:1998PNAS…95.8630G. doi:10.1073/pnas.95.15.8630. PMC 21127. PMID 9671729.
- Collins CS, Gould SJ (1999). “Identification of a common PEX1 mutation in Zellweger syndrome”. Hum. Mutat. 14 (1): 45–53. doi:10.1002/(SICI)1098-1004(1999)14:1<45::AID-HUMU6>3.0.CO;2-J. PMID 10447258.
- Tamura S, Matsumoto N, Imamura A, et al. (2001). “Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction”. Biochem. J. 357 (Pt 2): 417–26. doi:10.1042/0264-6021:3570417. PMC 1221968. PMID 11439091.
- Preuss N, Brosius U, Biermanns M, et al. (2002). “PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease”. Pediatr. Res. 51 (6): 706–14. doi:10.1203/00006450-200206000-00008. PMID 12032265.
- Maxwell MA, Allen T, Solly PB, et al. (2003). “Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients”. Hum. Mutat. 20 (5): 342–51. doi:10.1002/humu.10128. PMID 12402331.
- Scherer SW, Cheung J, MacDonald JR, et al. (2003). “Human chromosome 7: DNA sequence and biology”. Science. 300 (5620): 767–72. Bibcode:2003Sci…300..767S. doi:10.1126/science.1083423. PMC 2882961. PMID 12690205.
- Matsumoto N, Tamura S, Fujiki Y (2003). “The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes”. Nat. Cell Biol. 5 (5): 454–60. doi:10.1038/ncb982. PMID 12717447.
- Dodt G, Walter C (2004). “Study of mutant proteins with folding defects in cultured patient cells”. Methods Mol. Biol. 232: 165–73. doi:10.1385/1-59259-394-1:165. ISBN 1-59259-394-1. PMID 12840548.
|chapter=ignored (help) - Hillier LW, Fulton RS, Fulton LA, et al. (2003). “The DNA sequence of human chromosome 7”. Nature. 424 (6945): 157–64. Bibcode:2003Natur.424..157H. doi:10.1038/nature01782. PMID 12853948.
